Atlas Trials

Lestaurtinib, Cytarabine, and Idarubicin in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia

Clinical trial NCT00469859 · COMPLETED

Trial details

NCT number
NCT00469859
Sponsor
Children's Oncology Group
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Leukemia
Start date
2007-06-01
Primary completion
2010-03-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.